Latest News of APAM
What is rapamycin? Devotees claim the drug can slow down aging
By New York Post |
1 week ago
Rapamycin, a compound used in organ transplant patients, is gaining attention as an anti-aging drug. By inhibiting mTOR, it may reduce inflammation, promote autophagy, and potentially combat diseases ...
Aperam S.A.'s (AMS:APAM) biggest owners are private companies who got richer after stock soared 4.4% last week
By Yahoo! Finance |
2 weeks ago
Private companies own 41% of Aperam S.A., with the top 5 shareholders controlling 52% of the company. Institutional investors hold a significant stake, indicating confidence in the company's future. A...
Artisan Partners Asset Management Inc. (APAM) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance |
1 month ago
Artisan Partners Asset Management Inc. is an investment manager serving various clients globally. They offer equity and fixed income portfolios, investing in growth and value stocks as well as non-inv...
-
Aperam's (AMS:APAM) Problems Go Beyond Weak Profit
By Yahoo! Finance | 1 month agoAperam S.A.'s recent earnings had no surprises, leading to a subdued market reaction. However, concerns arise due to the significant contribution of unusual items to profit, indicating lower underlyin...
-
Commonly used drug may extend women's fertility, claim researchers - here's what you need to know about rapamycin
By CNN | 2 months agoStudies suggest rapamycin may extend a woman's fertility by delaying ovarian aging. Research in mice shows promise, with potential benefits for human fertility. Clinical trials are ongoing to confirm ...
-
Market is not liking Aperam's (AMS:APAM) earnings decline as stock retreats 3.1% this week
By Yahoo! Finance | 3 months agoAperam S.A. (AMS:APAM) stock has dropped significantly, with a 42% decrease in three years. While EPS declined by 40% annually, market sentiment remains uncertain....